Electrophysiologic analyses during chronic application of opioids to organotypic explants of fetal mouse spinal cord with attached dorsal root ganglia (DRGs) have provided the first demonstration that isolated mammalian CNS tissues can, in fact, develop a marked tolerance after several days' exposure in vitro.* Attempts will be made to clarify cellular mechanisms regulating development of tolerance and dependence in these unique CNS tissue cultures by introduction of specific metabolic and pharmacologic blocking agents and by other selective manipulations of the rigorously controlled physicochemical environment of these cultures. Extracellular recordings of the changes in DRG-evoked dorsal-horn network responses during chronic exposure to opioids will be correlated with intracellular recordings from the DRG neurons to detect possible functional alterations in presynaptic DRG terminals during development of tolerance, e.g. decreased opioid sensitivity, increased calcium conductance. Factors leading to the marked increase in opiate binding that occurs in our cord-DRG explants after chronic exposure to naloxone will be analyzed and similar methods will be used to detect possible changes in opiate receptor levels in tolerant cultures. Further studies of cross-tolerance between morphine and opioid peptides will be made to clarify the degree to which tolerance selective for receptor subtypes may develop in the dorsal-horn networks of cord-DRG explants. Development of cross-tolerance to the acute depressant effects of serotonin, and possibly to other monoamines, in opioid-tolerant cord-DRG explants will be analyzed with specific transmitter antagonists. Development of physiologic properties of opioid dorsal-horn networks and their DRG inputs will be studied in normal culture media and following chronic exposure to opioid agonists and antagonists introduced at early stages of maturation of fetal cord-DRG, and isolated DRG, explants in vitro. Correlative studies will be made with cord-DRG tissues explanted from pregnant rodents after chronic exposure to opioids in utero. The proposed studies should provide valuable insights into mechanisms of tolerance and plasticity in opioid systems of the CNS and to problems in maternal narcotic addiction. Crain et al., Life Sciences 25:1797-1802, 1979: 31:241-247, 1982.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002031-06
Application #
3207085
Study Section
(SRC)
Project Start
1978-07-01
Project End
1986-02-28
Budget Start
1985-03-01
Budget End
1986-02-28
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Shen, K F; Crain, S M (1994) Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells. J Neurosci 14:5570-9
Shen, K F; Crain, S M (1994) Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res 636:286-97
Cruciani, R A; Dvorkin, B; Klinger, H P et al. (1994) Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res 667:229-37
Cruciani, R A; Dvorkin, B; Morris, S A et al. (1993) Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A 90:3019-23
Fan, S F; Shen, K F; Crain, S M (1993) mu and delta opioid agonists at low concentrations decrease voltage-dependent K+ currents in F11 neuroblastoma x DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res 605:214-20
Crain, S M; Shen, K F (1992) After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J Pharmacol Exp Ther 260:182-6
Shen, K F; Crain, S M (1992) Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Res 597:74-83
Crain, S M; Shen, K F (1992) After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res 575:13-24
Fan, S F; Shen, K F; Scheideler, M A et al. (1992) F11 neuroblastoma x DRG neuron hybrid cells express inhibitory mu- and delta-opioid receptors which increase voltage-dependent K+ currents upon activation. Brain Res 590:329-33
Terwilliger, R Z; Beitner-Johnson, D; Sevarino, K A et al. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-10

Showing the most recent 10 out of 28 publications